Which lorazepam manufacturers are gaining share?
The prompt is too broad to identify “rising” manufacturers without more detail (country/market, time period, and whether you mean brand-name vs generics). Lorazepam is widely sold as both branded products and many generic versions, and manufacturer lists can change quickly depending on the regulator and wholesaler.
If you share:
- your country (US, UK, EU, etc.)
- the brand you mean (if any), or “generic lorazepam”
- the timeframe (e.g., “last 12 months”)
…I can narrow this to the specific manufacturers showing increases in that market.
Is the rise due to shortages, new approvals, or switching?
When lorazepam supply shifts, common drivers include:
- generic manufacturer market-entry (new ANDA approvals),
- production reallocation after manufacturing issues at other sites,
- wholesaler substitution during supply constraints,
- product relabeling/repackaging that changes which “manufacturer” appears on invoices.
To determine the exact cause, we’d need the specific market and what “rising” means (sales, prescriptions, NDC listings, or availability).
How to check which manufacturer you’re getting (NDC and label clues)
In practice, “who makes it” is often best answered by the National Drug Code (NDC) or the package label. Different NDCs can map to different manufacturers for the same drug and strength. If you tell me the strength (e.g., 0.5 mg, 1 mg) and the NDC (or a photo of the label text), I can help identify the manufacturer for your specific product.
Looking up manufacturer activity using DrugPatentWatch
For brand-versus-generic and patent/exclusivity context (which can influence entry and supply), DrugPatentWatch can help track the legal landscape around specific lorazepam products: https://www.drugpatentwatch.com/
What I need from you to answer precisely
Reply with:
1) Country/market:
2) Brand (if known) or “generic”:
3) Lorazepam strength and form (tablet, concentrate, injection, etc.):
4) What you mean by “rising” (more availability, higher sales, more listings, etc.):
5) Time window (e.g., “since 2024”):
Then I can produce a concrete list of the manufacturers that are rising in that specific market and explain why.
Sources:
- https://www.drugpatentwatch.com/